IPO Listed — 15 Dec 2025
Listing Price: ₹1470 (+38.42% vs ₹1062)
Corona Remedies IPO Review
Corona Remedies IPO has been reviewed by 15 analysts, and the overall consensus is Strong Apply — carrying a score of 100. Out of the 15 analysts who have covered this IPO, 15 recommend subscribing — reflecting a mixed view from the analyst community.
The issue is priced in the band of ₹₹1,008 – ₹1,062 per share , with a minimum application size of 14 shares . Subscription ran from 08 Dec 2025 to 10 Dec 2025. As of now, the grey market premium (GMP) for Corona Remedies IPO is quoting at ₹300 (484%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.
Table of Contents
Recommend Subscribe
Based on 15 analyst reviews
Higher consensus indicates broader analyst agreement.
Analyst Review
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Corona Remedies IPO?
Based on analyst coverage tracked on this page, the overall verdict for Corona Remedies IPO is Strong Apply. Out of 15 analysts who have reviewed this IPO, 15 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.
What does the score of 100 mean for Corona Remedies IPO?
The score of 100 is an aggregate of all analyst ratings tracked for Corona Remedies IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.
What was the actual listing price of Corona Remedies IPO?
Corona Remedies IPO listed on December 15, 2025 at ₹1470 , against the issue price of ₹1062 — a gain of +38.42% (₹408 per share). View the full GMP history page for day-wise pre-listing trends.
What is the price band and lot size of Corona Remedies IPO?
Corona Remedies IPO was priced at ₹₹1,008 – ₹1,062 per share. The minimum lot size is 14 shares. Subscription ran from 08 Dec 2025 to 10 Dec 2025.
Explore Corona Remedies IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!